AMANDA BENDER: Open Payments
NPI 1962867341 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 14 payments from 9 companies in 2025. Trend: 2023 $1,008 · 2024 $751 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $65 |
| Galderma Laboratories, L.P. | 3 | $52 |
| UCB, Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| ABBVIE INC. | 2 | $30 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $28 |
| LEO Pharma Inc. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
| Organon LLC | 1 | $8 |
Products named: TREMFYA, Bimzelx, NEMLUVIO, SPEVIGO, Cequa, ADBRY, AKLIEF, SKYRIZI.
Industry payments across PA — which companies pay providers there.
